401 related articles for article (PubMed ID: 11196646)
1. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.
Soengas MS; Capodieci P; Polsky D; Mora J; Esteller M; Opitz-Araya X; McCombie R; Herman JG; Gerald WL; Lazebnik YA; Cordón-Cardó C; Lowe SW
Nature; 2001 Jan; 409(6817):207-11. PubMed ID: 11196646
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
Zanon M; Piris A; Bersani I; Vegetti C; Molla A; Scarito A; Anichini A
Cancer Res; 2004 Oct; 64(20):7386-94. PubMed ID: 15492260
[TBL] [Abstract][Full Text] [Related]
3. Analysis of APAF-1 expression in human cutaneous melanoma progression.
Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.
Ho CK; Li G
Br J Dermatol; 2005 Nov; 153(5):900-10. PubMed ID: 16225598
[TBL] [Abstract][Full Text] [Related]
5. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
6. APAF-1 signaling in human melanoma.
Anichini A; Mortarini R; Sensi M; Zanon M
Cancer Lett; 2006 Jul; 238(2):168-79. PubMed ID: 16095810
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of Apaf-1 with progression of melanoma.
Mustika R; Budiyanto A; Nishigori C; Ichihashi M; Ueda M
Pigment Cell Res; 2005 Feb; 18(1):59-62. PubMed ID: 15649154
[TBL] [Abstract][Full Text] [Related]
8. Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.
Fujimoto A; Takeuchi H; Taback B; Hsueh EC; Elashoff D; Morton DL; Hoon DS
Cancer Res; 2004 Mar; 64(6):2245-50. PubMed ID: 15026369
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death.
Meyer K; Basu A; Saito K; Ray RB; Ray R
Virology; 2005 Jun; 336(2):198-207. PubMed ID: 15892961
[TBL] [Abstract][Full Text] [Related]
10. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
11. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
Robles AI; Bemmels NA; Foraker AB; Harris CC
Cancer Res; 2001 Sep; 61(18):6660-4. PubMed ID: 11559530
[TBL] [Abstract][Full Text] [Related]
12. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
Bush JA; Cheung KJ; Li G
Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance.
Liu JR; Opipari AW; Tan L; Jiang Y; Zhang Y; Tang H; Nuñez G
Cancer Res; 2002 Feb; 62(3):924-31. PubMed ID: 11830553
[TBL] [Abstract][Full Text] [Related]
14. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of the apoptosis effector Apaf-1 in melanoma.
Peltenburg LT; de Bruin EC; Meersma D; Smit NP; Schrier PI; Medema JP
Cell Death Differ; 2005 Jun; 12(6):678-9. PubMed ID: 15832175
[No Abstract] [Full Text] [Related]
16. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.
Tomicic MT; Christmann M; Kaina B
Apoptosis; 2005 Dec; 10(6):1295-304. PubMed ID: 16215690
[TBL] [Abstract][Full Text] [Related]
17. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
18. [Expression and promoter methylation of Apaf-1 gene in laryngeal squamous cell carcinoma].
Huang DF; Fu WN; Shang C; Xu ZM; Li ZG; Sun KL
Yi Chuan Xue Bao; 2004 Dec; 31(12):1327-31. PubMed ID: 15633635
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina.
Wallace DM; Donovan M; Cotter TG
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2765-72. PubMed ID: 16799012
[TBL] [Abstract][Full Text] [Related]
20. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
